Invesco Gold & Special Minerals Fund A USD Acc vs UBS Lux Equity Fund Biotech USD

Invesco Gold & Special Minerals Fund A USD Acc vs UBS Lux Equity Fund Biotech USD

1. Invesco Gold & Special Minerals Fund A USD Acc

  • Verdipapir

    Invesco Gold & Special Minerals Fund A USD Acc

  • Gebyr

    2.00%

  • ISIN

    LU0505655562

  • Beholdninger

    10

2. UBS Lux Equity Fund Biotech USD

  • Verdipapir

    UBS Lux Equity Fund Biotech USD P-acc

  • Gebyr

    2.25%

  • ISIN

    LU0069152568

  • Beholdninger

    9

Fondsbeholdning

Vi har information om 14 beholdninger i Invesco Gold & Special Minerals Fund A USD Acc, hvor den største beholdningen er Northern Star Resources (4.86%), etterfulgt av Agnico Eagle Mines (3.6%) og Newmont (3.55%). Sammenligner vi med UBS Lux Equity Fund Biotech USD har vi der 11 beholdninger hvor Regeneron Pharmaceuticals er største beholdningen (10.04%), etterfulgt av Moderna (9.21%) og Vertex (8.44%).

Alle beholdninger

Her sammenligner vi beholdningene i Invesco Gold & Special Minerals Fund A USD Acc og UBS Lux Equity Fund Biotech USD.

Invesco Gold & Special Minerals Fund A USD Acc UBS Lux Equity Fund Biotech USD
1. Northern Star Resources Ltd
Australia
4.86 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Agnico Eagle Mines Ltd
Canada
3.6 %
2. Moderna Inc
9.21 %
3. Newmont Corp
USA
3.55 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. OceanaGold Corp
Australia
3.53 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Artemis Gold Inc
Canada
3.32 %
5. AbbVie Inc
USA
4.91 %
6. K92 Mining Inc
Canada
3.32 %
6. Gilead Sciences Inc
USA
4.66 %
7. Barrick Mining Corp
USA
3.28 %
7. Amgen Inc
USA
4.43 %
8. Anglogold Ashanti Ltd
Sør-Afrika
2.98 %
8. BioNTech SE
4.13 %
9. Kinross Gold Corp
Canada
2.9 %
9. Karuna Therapeutics Inc
3.75 %
10. Gold Fields ADR
Sør-Afrika
2.9 %
-

Listen over fondsbeholdning ble sist oppdatert 22 juli 2025.